The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and are anticipated to grow at a CAGR of 7.2% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 2.6 Billion.
The industry is expected to expand as preventative medication is utilized more often and cardiovascular diseases (CVDs) become more common. The COVID-19 pandemic had a detrimental effect on outpatient imaging services, which restrained worldwide market expansion.
The three leading causes of death in the country are heart disease, heart attacks, and stroke. The propensity to CVD has increased due to changing lifestyles. The CDC reports that 28.2 million Americans received a heart disease diagnosis in 2017. The function of the heart’s valves, plaque buildup, and cardiac pumping capability are all examined using ultrasound technology.
Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16514
Ultrasound imaging is a noninvasive medical diagnostic tool that helps doctors diagnose and treat medical issues. The images of the veins and arteries in the body are produced by vascular ultrasonography.
A Doppler ultrasound scan is often part of a vascular ultrasound evaluation. They can also show blood flowing through arteries. The global cardiovascular ultrasound treatment market is being driven by factors such as the rising prevalence of heart diseases and the growing acceptability of cardiovascular ultrasound systems over older invasive cardiac diagnostic procedures.
Echocardiography, also known as echocardiography, is a medical imaging technique that uses high-frequency sound waves to produce images of the heart and surrounding blood vessels. This non-invasive test is used to evaluate the structure and function of the heart, as well as detect abnormalities and diagnose various cardiovascular diseases.
Competitive Landscape
- GE Healthcare
- Koninklijke Philips
- Siemens Healthineers AG
- Hitachi Medical Corp.
- Samsung Medison Co. Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
- Fujifilm Sonosite, Inc
Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16514
Some of the recent developments of key Cardiovascular Ultrasound providers are as follows:
- In October 2020, GE Healthcare got FDA 510k clearance for their extreme edition package of vivid cardiovascular ultrasound devices, which contains new artificial intelligence (AI)-based features that enable doctors to obtain faster, more consistent assessments.
- In October 2020, Royal Philips introduced the Ultrasound 3300 in India. OB/GYN, cardiovascular imaging, and general imaging are a few of the applications for the device.
- In August 2020, Philips announced the release of its new Affiniti CVx and 7.0 for EPIQ CVx cardiovascular ultrasound systems, which include enhancements to boost diagnostic confidence and improve the user experience.
Market Segments Covered in Cardiovascular Ultrasound Market Analysis
By Type:
- Fetal Echocardiography
- Transthoracic Echocardiography
- Transesophageal Echocardiography
- Others
By Technology:
- 2D
- 3D/4D
- Doppler
Click here today to buy your full report @ https://www.futuremarketinsights.com/checkout/16514
By Display Type:
- B/W
- Color
By End-use:
- Hospitals
- Diagnostic Centers
- Ambulatory Care Centers
- Other End-uses
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
